Showing results (1671-1680 of 1,768) with videos related to

Sort By:
Pageof 177
Gut|September 16, 2011
Effects of selective COX-2 inhibitor and Helicobacter pylori eradication on precancerous gastric lesionsBenjamin C Y Wong, Lian Zhang, Jun-ling Ma, et al.
Bioorganic & Medicinal Chemistry Letters|October 26, 2005
Peptide inhibitors of dengue virus NS3 protease. Part 2: SAR study of tetrapeptide aldehyde inhibitorsZheng Yin, Sejal J Patel, Wei-Ling Wang, et al.
Theranostics|April 16, 2021
Exosomal miR-125b-5p deriving from mesenchymal stem cells promotes tubular repair by suppression of p53 in ischemic acute kidney injuryJing-Yuan Cao, Bin Wang, Tao-Tao Tang, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|September 24, 2013
[Comparison of two gastric cancer screening schemes in a high-risk population]Yan-li Lü, Yi Li, Guang-shun Liu, et al.
Clinical Pharmacology in Drug Development|July 18, 2022
Pharmacokinetic Characteristics, Safety, and Tolerability of Telitacicept, an Injectable Recombinant Human B-Lymphocyte Stimulating Factor Receptor-Antibody Fusion Protein, in Healthy Chinese SubjectsJing Xie, Xiaoyun Fan, Yue Su, et al.
Theranostics|March 23, 2021
GPR43 deficiency protects against podocyte insulin resistance in diabetic nephropathy through the restoration of AMPKα activityJian Lu, Pei Pei Chen, Jia Xiu Zhang, et al.
Environment International|June 27, 2020
Body mass, mercury exposure, biochemistry and untargeted metabolomics of incubating common eiders (Somateria mollissima) in three Baltic coloniesNyuk Ling Ma, Martin Hansen, Ole Roland Therkildsen, et al.
Theranostics|June 10, 2024
Erratum: Exosomal miR-125b-5p deriving from mesenchymal stem cells promotes tubular repair by suppression of p53 in ischemic acute kidney injury: ErratumJing-Yuan Cao, Bin Wang, Tao-Tao Tang, et al.
Dementia and Geriatric Cognitive Disorders|August 24, 2006
Apolipoprotein E epsilon4 allele is associated with vascular dementiaLarry Baum, Linda C W Lam, Timothy Kwok, et al.
Cancer|September 8, 2016
A multicenter, single-arm, open-label, phase 2 study of apitolisib (GDC-0980) for the treatment of recurrent or persistent endometrial carcinoma (MAGGIE study)Vicky Makker, Fernando O Recio, Ling Ma, et al.
Pageof 177